Kang Chen1,2, Bi-zhu Chu1,2, Feng Liu2,3, Bin Li1,2, Chun-mei Gao2,3, Lu-lu Li2, Qin-sheng Sun2, Zhi-fa Shen4, Yu-yang Jiang2,3,5. 1. Department of Chemistry, Tsinghua University, Beijing 100084, China. 2. The Ministry-Province Jointly Constructed Base for State Key Lab-Shenzhen Key Laboratory of Chemical Biology, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China. 3. Shenzhen Anti-Tumor Drug Development Engineering Laboratory, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China. 4. Shenzhen Kivita Innovative Drug Discovery Institute, Shenzhen 518055, China. 5. School of Medicine, Tsinghua University, Beijing 100084, China.
Abstract
AIM: To investigate the mechanisms underlying anticancer action of the benzimidazole acridine derivative N-{(1H-benzo[d]imidazol-2-yl)methyl}-2-butylacridin-9-amine(8m) against human colon cancer cells in vitro. METHODS: Human colon cancer cell lines SW480 and HCT116 were incubated in the presence of 8m, and then the cell proliferation and apoptosis were measured. The expression of apoptotic/signaling genes and proteins was detected using RT-PCR and Western blotting. ROS generation and mitochondrial membrane depolarization were visualized with fluorescence microscopy. RESULTS: 8m dose-dependently suppressed the proliferation of SW480 and HCT116 cells with IC50 values of 6.77 and 3.33 μmol/L, respectively. 8m induced apoptosis of HCT116 cells, accompanied by down-regulation of Bcl-2, up-regulation of death receptor-5 (DR5), truncation of Bid, cleavage of PARP, and activation of caspases (including caspase-8 and caspase-9 as well as the downstream caspases-3 and caspase-7). Moreover, 8m selectively activated JNK and p38 without affecting ERK in HCT116 cells. Knockout of JNK1, but not p38, attenuated 8m-induced apoptosis. In addition, 8m induced ROS production and mitochondrial membrane depolarization in HCT116 cells. Pretreatment with the antioxidants N-acetyl cysteine or glutathione attenuated 8m-induced apoptosis and JNK activation in HCT116 cells. CONCLUSION: The new benzimidazole acridine derivative, 8m exerts anticancer activity against human colon cancer cells in vitro by inducing both intrinsic and extrinsic apoptosis pathways via the ROS-JNK1 pathway.
AIM: To investigate the mechanisms underlying anticancer action of the benzimidazole acridine derivative N-{(1H-benzo[d]imidazol-2-yl)methyl}-2-butylacridin-9-amine(8m) against humancolon cancer cells in vitro. METHODS:Humancolon cancer cell lines SW480 and HCT116 were incubated in the presence of 8m, and then the cell proliferation and apoptosis were measured. The expression of apoptotic/signaling genes and proteins was detected using RT-PCR and Western blotting. ROS generation and mitochondrial membrane depolarization were visualized with fluorescence microscopy. RESULTS: 8m dose-dependently suppressed the proliferation of SW480 and HCT116 cells with IC50 values of 6.77 and 3.33 μmol/L, respectively. 8m induced apoptosis of HCT116 cells, accompanied by down-regulation of Bcl-2, up-regulation of death receptor-5 (DR5), truncation of Bid, cleavage of PARP, and activation of caspases (including caspase-8 and caspase-9 as well as the downstream caspases-3 and caspase-7). Moreover, 8m selectively activated JNK and p38 without affecting ERK in HCT116 cells. Knockout of JNK1, but not p38, attenuated 8m-induced apoptosis. In addition, 8m induced ROS production and mitochondrial membrane depolarization in HCT116 cells. Pretreatment with the antioxidants N-acetyl cysteine or glutathione attenuated 8m-induced apoptosis and JNK activation in HCT116 cells. CONCLUSION: The new benzimidazole acridine derivative, 8m exerts anticancer activity against humancolon cancer cells in vitro by inducing both intrinsic and extrinsic apoptosis pathways via the ROS-JNK1 pathway.
Authors: Gelin Wang; Xiaoming Wang; Hong Yu; Shuguang Wei; Noelle Williams; Daniel L Holmes; Randal Halfmann; Jacinth Naidoo; Lai Wang; Lin Li; She Chen; Patrick Harran; Xiaoguang Lei; Xiaodong Wang Journal: Nat Chem Biol Date: 2012-12-23 Impact factor: 15.040
Authors: M Cem Koçkar; Mustafa Nazıroğlu; Omer Celik; H Tahsin Tola; Dilek Bayram; Ahmet Koyu Journal: Cell Biochem Funct Date: 2010-11-08 Impact factor: 3.685
Authors: Wendy L Allen; Vicky M Coyle; Puthen V Jithesh; Irina Proutski; Leanne Stevenson; Cathy Fenning; Daniel B Longley; Richard H Wilson; Michael Gordon; Heinz-Josef Lenz; Patrick G Johnston Journal: Clin Cancer Res Date: 2008-10-15 Impact factor: 12.531
Authors: Jennifer I Hare; Robert W Neijzen; Malathi Anantha; Nancy Dos Santos; Natashia Harasym; Murray S Webb; Theresa M Allen; Marcel B Bally; Dawn N Waterhouse Journal: PLoS One Date: 2013-04-23 Impact factor: 3.240
Authors: Ashok Agarwal; Reda Z Mahfouz; Rakesh K Sharma; Oli Sarkar; Devna Mangrola; Premendu P Mathur Journal: Reprod Biol Endocrinol Date: 2009-12-05 Impact factor: 5.211